Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanism
- 13 December 2007
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 193 (1-2) , 12-23
- https://doi.org/10.1016/j.jneuroim.2007.07.025
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Sca-1 expression is associated with decreased cardiomyogenic differentiation potential of skeletal muscle-derived adult primitive cellsJournal of Molecular and Cellular Cardiology, 2006
- Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan MetaboliteScience, 2005
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergyBlood, 2005
- Bone marrow as a home of heterogenous populations of nonhematopoietic stem cellsLeukemia, 2005
- Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsivenessBlood, 2005
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosisNature, 2003
- Interferon γ Is Required for Activation-induced Death of T LymphocytesThe Journal of Experimental Medicine, 2002
- From Marrow to Brain: Expression of Neuronal Phenotypes in Adult MiceScience, 2000
- Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?Immunology Today, 1999